Abstract:MHC class II (MHCII) genes are transactivated by the NOD-like receptor (NLR) family member CIITA, which is recruited to SXY enhancers of MHCII promoters via a DNA-binding "enhanceosome" complex. NLRC5, another NLR protein, was recently found to control transcription of MHC class I (MHCI) genes. However, detailed understanding of NLRC5's target gene specificity and mechanism of action remained lacking. We performed ChIP-sequencing experiments to gain comprehensive information on NLRC5-regulated genes. In addition to classical MHCI genes, we exclusively identified novel targets encoding non-classical MHCI molecules having important functions in immunity and tolerance. ChIP-sequencing performed with Rfx5(-/-) cells, which lack the pivotal enhanceosome factor RFX5, demonstrated its strict requirement for NLRC5 recruitment. Accordingly, Rfx5-knockout mice phenocopy Nlrc5 deficiency with respect to defective MHCI expression. Analysis of B cell lines lacking RFX5, RFXAP, or RFXANK further corroborated the importance of the enhanceosome for MHCI expression. Although recruited by common DNA-binding factors, CIITA and NLRC5 exhibit non-redundant functions, shown here using double-deficient Nlrc5(-/-)CIIta(-/-) mice. These paradoxical findings were resolved by using a "de novo" motif-discovery approach showing that the SXY consensus sequence occupied by NLRC5 in vivo diverges significantly from that occupied by CIITA. These sequence differences were sufficient to determine preferential occupation and transactivation by NLRC5 or CIITA, respectively, and the S box was found to be the essential feature conferring NLRC5 specificity. These results broaden our knowledge on the transcriptional activities of NLRC5 and CIITA, revealing their dependence on shared enhanceosome factors but their recruitment to distinct enhancer motifs in vivo. Furthermore, we demonstrated selectivity of NLRC5 for genes encoding MHCI or related proteins, rendering it an attractive target for therapeutic intervention. NLRC5 and CIITA thus emerge as paradigms for a novel class of transcriptional regulators dedicated for transactivating extremely few, phylogenetically related genes.

Transcriptional control of murine CD94 gene: differential usage of dual promoters by lymphoid cell types

Qa-1(b)-dependent modulation of dendritic cell and NK cell cross-talk in vivo.

Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses

Nucleoprotein Structure Of The Cd4 Locus: Implications For The Mechanisms Underlying Cd4 Regulation During T Cell Development

Structure of the murine CD94–NKG2A receptor in complex with Qa‐1b presenting an MHC‐I leader peptide

Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor.

Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes

Transcriptome landscape of double negative T cells by single-cell RNA sequencing

Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells

Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation

Hemopoietic lineage commitment decisions: in vivo evidence from a transgenic mouse model harboring micro LCR-betapro-LacZ as a transgene

Differences in Expression of Toll-Like Receptors and Their Reactivities in Dendritic Cells in BALB/c and C57BL/6 Mice.

Host MHC class I molecules modulate in vivo expression of a NK cell receptor.

Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene.

Tox4 Regulates Transcriptional Elongation and Reinitiation During Murine T Cell Development

Ly49C-Dependent Control of MCMV Infection by NK Cells Is Cis-Regulated by MHC Class I Molecules

Dynamic Transcription of Long Non-Coding Rna Genes During Cd4+T Cell Development and Activation

NLRC5 Exclusively Transactivates MHC Class I and Related Genes through a Distinctive SXY Module

Cutting edge: CD94/NKG2 is expressed on Th1 but not Th2 cells and costimulates Th1 effector functions

Cloning of minimally divergent allelic forms of the natural killer (NK) receptor Ly-49C, differentially controlled by host genes in the MHC and NK gene complexes.

Functional and Ontogenetic Analysis of Murine CD45Rhi and CD45Rlo CD4+ T Cells.